| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/09/2009 | US20090094704 for determining bioactive intact PTH levels in serum, plasma, and/or cell culture media; have a novel recognition for amino acid residues extending beyond the first N-terminal PTH residue; have binding affinity and specificity for PTH that have mitigated cross-reactivity to large non (1-84) PTH fragments |
| 04/09/2009 | US20090093622 BASB029 polynucleotide(s) and polypeptides from Neisseria meningitidis |
| 04/09/2009 | US20090093618 Streptavidin-biotin-link antibody-hapten system |
| 04/09/2009 | US20090093617 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 04/09/2009 | US20090093400 Truncated keratinocyte growth factor (KGF) having increased biological activity |
| 04/09/2009 | US20090093398 Use of Fibroblast Growth Factor Fragments |
| 04/09/2009 | US20090093069 Topiramate Immunoassays |
| 04/09/2009 | US20090093066 Glycated peptides and methods of use |
| 04/09/2009 | US20090093057 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 04/09/2009 | US20090093052 Human Hematopoietic Stem And Progenitor Antigen And Methods For Its Use |
| 04/09/2009 | US20090093051 T1R1 Nucleic Acid Sequences and Vectors Containing Same |
| 04/09/2009 | US20090093021 Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
| 04/09/2009 | US20090093002 Humanized antibody |
| 04/09/2009 | US20090093000 Glycoprotein and apolipoprotein biopolymer markers predictive of Alzheimers disease |
| 04/09/2009 | US20090092622 Molecules, compositions, methods and kits for applications associated with flaviviruses |
| 04/09/2009 | US20090092621 Antibodies for preventing and treating attaching and effacing escherichia coli (aeec) associated diseases |
| 04/09/2009 | US20090092620 Flu virus hemagglutinin specific monoclonal antibodies |
| 04/09/2009 | US20090092619 Methods and compositions for malaria prophylaxis |
| 04/09/2009 | US20090092618 Peptide-based immunization therapy for treatment of atherosclerosis |
| 04/09/2009 | US20090092617 Erbb Receptor-Derived Peptide Fragments |
| 04/09/2009 | US20090092616 ZNF206: A Novel Regulator of Embryonic Stem Cell Self-renewal and Pluripotency |
| 04/09/2009 | US20090092615 biodrugs select from an oligopeptide, or polypeptide; anticarcinogenic agent for treating lung cancer cell, adenocarcinoma cell; combination therapy using standard anti-cancer protocols in conjunction with Notch proteins |
| 04/09/2009 | US20090092613 Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding |
| 04/09/2009 | US20090092612 Anti-platelet membrane glycoprotein vi monoclonal antibody |
| 04/09/2009 | US20090092611 Antibodies that bind both bcma and taci |
| 04/09/2009 | US20090092610 FcGammaRIIB Specific Antibodies and Methods of Use Thereof |
| 04/09/2009 | US20090092609 Monoclonal antibodies to respiratory syncytial virus and uses therefor |
| 04/09/2009 | US20090092608 Human Tumor Necrosis Factor Receptor-Like 2 |
| 04/09/2009 | US20090092607 Fc-erythropoietin fusion protein with improved pharmacokinetics |
| 04/09/2009 | US20090092606 Antibacterial treatments |
| 04/09/2009 | US20090092605 Compositions and methods for the treatment of immune related diseases |
| 04/09/2009 | US20090092602 Use of anti-tissue factor antibodies for treating thromboses |
| 04/09/2009 | US20090092601 HUMANIZED ANTI-LT-beta-R ANTIBODIES |
| 04/09/2009 | US20090092599 Optimized Fc variants and methods for their generation |
| 04/09/2009 | US20090092598 administering anti-CEA (carcinogenicembryonic antigen) monoclonal antibody (MAb) or fragment and a drug selected from vincristine, doxorubicin, dacarbazine (DTIC), cyclophosphamide, CPT-11, oxaliplatin, gemcitabine and 5-fluorouracil/leucovorin |
| 04/09/2009 | US20090092597 Mammalian cell surface antigens; related reagents |
| 04/09/2009 | US20090092594 Mammalian genes involved in viral infection and tumor suppression |
| 04/09/2009 | US20090092592 Methionyl tRNA Synthetase Polynucleotides |
| 04/09/2009 | US20090092581 Interferons of rhesus and cynomolgus origin and uses thereof |
| 04/09/2009 | US20090092579 Novel method for down-regulation of amyloid |
| 04/09/2009 | US20090092557 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 04/09/2009 | US20090092546 Carrier molecules |
| 04/09/2009 | US20090092545 Antibodies that bind both bcma and taci |
| 04/09/2009 | US20090092544 Tumor diagnostic agent used in PET comprising anti-ROBO1 antibody |
| 04/09/2009 | DE102007045935A1 Fertilitätstest Fertility Test |
| 04/09/2009 | CA2734139A1 Antibody therapy for use in the digestive tract |
| 04/09/2009 | CA2701846A1 Extracellular targets for alzheimer's disease |
| 04/09/2009 | CA2701694A1 Antigen-binding proteins having specificity for human hepcidin |
| 04/09/2009 | CA2701608A1 Novel compositions and methods for stimulating erythropoiesis in a mammal |
| 04/09/2009 | CA2701429A1 Crystalline egfr - matuzumab complex and matuzumab mimetics obtained thereof |
| 04/09/2009 | CA2700860A1 Human antibodies that bind mesothelin, and uses thereof |
| 04/09/2009 | CA2700758A1 Immunoglobulins |
| 04/09/2009 | CA2700410A1 Treatment of proliferative disorders using antibodies to psma |
| 04/09/2009 | CA2700011A1 Cc2d2a gene mutations associated with joubert syndrome and diagnostic methods for identifying the same |
| 04/09/2009 | CA2699601A1 Nlrr-1 antagonists and uses thereof |
| 04/09/2009 | CA2696417A1 Therapeutic antibody purification method and method of use |
| 04/08/2009 | EP2045604A1 Method for examining WT1-related disease |
| 04/08/2009 | EP2045268A1 Mhc class I and II peptide antigens derived from tumour antigen 5t4 |
| 04/08/2009 | EP2045267A2 Humanized antibodies that recognize beta amyloid peptide |
| 04/08/2009 | EP2045261A1 Chlamydia pneumoniae antigenic polypeptides |
| 04/08/2009 | EP2044955A2 Methods for detecting and inhibiting angiogenesis |
| 04/08/2009 | EP2044954A1 Treatment of fungal infections |
| 04/08/2009 | EP2044950A2 Attenuated VIF DNA immunization cassettes for genetic vaccines |
| 04/08/2009 | EP2044839A2 Production of humanized antibodies in transgenic animals |
| 04/08/2009 | EP2044443A2 Peptide antibody depletion and its application to mass spectrometry sample preparation |
| 04/08/2009 | EP2044125A1 Compositions and methods for delivering anti-activated ras antibodies into cells |
| 04/08/2009 | EP2044124A2 Methods and compositions for targeting hepsin |
| 04/08/2009 | EP2044123A1 Tumor-targeting monoclonal antibodies to fzd10 and uses thereof |
| 04/08/2009 | EP2044122A2 Antagonist antibody against epha2 for the treatment of cancer |
| 04/08/2009 | EP2044121A2 Glyco-enqineered antibodies |
| 04/08/2009 | EP2044120A2 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same |
| 04/08/2009 | EP2044119A1 Cancerous disease modifying antibodies |
| 04/08/2009 | EP2044118A2 Il-17 and il-23 antagonists and methods of using the same |
| 04/08/2009 | EP2044117A2 Method for engineering immunoglobulins |
| 04/08/2009 | EP2043687A2 Anti-amyloid antibodies, compositions, methods and uses |
| 04/08/2009 | EP2043686A2 Antagonists of protease activated receptor-1 (par1) |
| 04/08/2009 | EP1931711B1 Antibodies against 25-hydroxyvitamin d |
| 04/08/2009 | EP1673393B1 Methods, kits, and compositions for the development and use of monoclonal antibodies specific to antigens of low immunogenicity |
| 04/08/2009 | EP1559318B1 Transgenic mammal carrying ganp gene transferred thereinto and utilization thereof |
| 04/08/2009 | EP1519749B1 Chemotactic factor inhibitor for inhibiting inflammatory reactions |
| 04/08/2009 | EP1505076B1 Specific antibody fragments for the human carcinoembryonic antigen (cea) |
| 04/08/2009 | EP1476468B9 Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity |
| 04/08/2009 | EP1244692B1 Compositions and methods for detecting stress-inducible proteins |
| 04/08/2009 | EP1096953B1 Use of inactivated immunosuppressive and/or angiogenic immunogenic proteins, preparation method and pharmaceutical or vaccine uses |
| 04/08/2009 | EP1007569B1 Stimulation of an immune response with antibodies labeled with the alpha-galactosyl epitope |
| 04/08/2009 | EP0877758B1 PURIFIED SR-p70 PROTEIN |
| 04/08/2009 | CN101405408A Methods of increasing lymphatic function |
| 04/08/2009 | CN101405300A Methods and compositions for antagonism of RAGE |
| 04/08/2009 | CN101405298A Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use |
| 04/08/2009 | CN101405030A Tumor therapy with an antibody for vascular endothelial groeth factor and an antibody for human epithelial growth factor receptor type 2 |
| 04/08/2009 | CN101402960A Recombinant rubella virus E1 protein and uses thereof |
| 04/08/2009 | CN101402956A Neutralizing human anti-IGFR antibody |
| 04/08/2009 | CN101402955A Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 04/08/2009 | CN101402686A Antihuman Endoglin single-chain antibody, preparation and uses thereof |
| 04/08/2009 | CN101402685A Neutralizing human anti-IGFR antibody |
| 04/08/2009 | CN101402684A Monoclone mab-bomDpl-9 of antibody anti-cattle maturity Doppel and uses thereof |
| 04/08/2009 | CN101402674A Functional peptide segment of epididymis protease inhibitors and uses thereof |
| 04/08/2009 | CN101402673A Method for extracting immunoglobulin of yolk |
| 04/08/2009 | CN101402671A Method simultaneously separating fibrinogen and immunoglobulin from livestock and poultry blood |
| 04/08/2009 | CN101401938A Neutralizing human anti-IGFR antibody |